Voyager Therapeutics, Inc. (BMV:VYGR)

Mexico flag Mexico · Delayed Price · Currency is MXN
58.00
-4.00 (-6.45%)
At close: Jul 18, 2025
-6.45%
Market Cap3.32B
Revenue (ttm)1.37B
Net Income (ttm)-1.73B
Shares Outn/a
EPS (ttm)-29.86
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40
Average Volume833
Open58.00
Previous Close62.00
Day's Range58.00 - 58.00
52-Week Range58.00 - 167.00
Betan/a
RSI29.98
Earnings DateAug 7, 2025

About United States Steel

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company’s lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer’s disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treat... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 172
Stock Exchange Mexican Stock Exchange
Ticker Symbol VYGR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.